|
Post by mnkdfann on May 19, 2022 12:16:06 GMT -5
This is the exciting sort of live CNBC coverage we can expect on Monday: www.cnbc.com/opening-bell/Basically, blink and you miss it. On a good day, the Squawk Box host might pronounce your corporate name correctly.
|
|
|
Post by mnkdfann on Mar 9, 2022 19:01:14 GMT -5
There are ways to support diabetics in Ukraine, but I do not think that shipping Afrezza is a good one. jdrf.org.uk/news/helping-the-diabetes-community-in-ukraine/www.jdrf.org/blog/2022/03/02/helping-the-diabetes-community-in-ukraine/Please do not attempt to ship supplies or insulin directly into Ukraine, as most normal shipping avenues have been blocked or restricted. All air travel in and out of Ukraine has been suspended due to military activity. The Ukrainian government is doing what it can to assist humanitarian supply convoys at the borders, but it is difficult with multiple checkpoints and military activity preventing shipments from arriving. The last thing we all want is for insulin and supplies to be thrown away because they were not delivered in the right way.We recognise that you may see individuals or organisations on social media asking for insulin or supplies to ship into Ukraine or into surrounding countries where refugees may go. While it is heartbreaking to see these requests, the best way to help these individuals at this time is to provide them with internal country resources to connect them with the closest medical clinic to get what they need.More at links, including ways to support Ukraine.
|
|
|
Post by mnkdfann on Feb 28, 2022 15:09:34 GMT -5
The reality is that MNKD stock has a 50% +/- ownership by institutions. They are not rushing the doors, or selling off major positions. They have dedicated research and analysis departments. Departments relying on performance for recognition and compensation. investors.mannkindcorp.com/stock-information/ownership-profileAs so many have pointed out here in the past, institutional ownership via index fund ETFs and the like doesn't really count for much. If you don't understand that, ask, and maybe a more patient poster than I will explain.
|
|
|
Post by mnkdfann on Feb 27, 2022 23:52:01 GMT -5
Sorry, this all sets off alarm bells for me, for several reasons, but both are ultimately my own value judgments and not necessarily indicative of anyone else on the board. One is that I have minimal interest in Kanye West or Kim K. or any K. for that matter. I don't want them in my life, and if Mike does, then to me that's points off for Mike. Second, the CEO of a previous investment/speculation disaster of mine did stuff that got people's attention (and not in a good way) so I hope this doesn't become a pattern. Just my .0002. It was over 4 years ago, so I wouldn't lose sleep over it. And, recall, his relationship wasn't with Kanye ... it was with Dame Dash, who was an Afrezza advocate at the time. The party was thrown by Kanye for Dash, and Mike was in attendance I guess because Dash was a Mannkind sort of guy at the time.
|
|
|
Post by mnkdfann on Feb 27, 2022 12:36:34 GMT -5
If you see my earlier post, you'll see that the actual quote from circa 1923 differs slightly from what you learned at Harvard. It is slightly amusing to me that Harvard missed / failed to give the source, but maybe the person who compiled the quotes there didn't want to be seen quoting ad copy from I.C.S. of Scranton? Researching quotes (and research in general) got much easier with the invention of hypertext and the search engine. There may be something to that (though I'm not sure it is so cut and dried, it actually makes my research life harder as so much is being digitized and going behind paywalls), but the quote in question was well known over several decades (say, 1920s to 60s) and even played a role in a Presidential campaign. So I do feel those Harvard course notes you mentioned may have been a bit sloppy with crediting in this case. Bartlett's Familiar Quotations, and similar reference texts, were widely available long before the Internet and search engines. Anyway, it is interesting that Harvard left out an important middle part of the quote (i.e. the "at the dawn of victory" bit).
|
|
|
Post by mnkdfann on Feb 27, 2022 10:58:44 GMT -5
“Upon the plains of hesitation bleached the bones of countless millions who sat down to WAIT and while waiting they died." - ANONYMOUS Love that. And you are very brave with all those bios! Thanks Sports...I found that quote many, many years ago while attending a course at the "Kennedy School of Government" at Harvard and have never forgotten it. The course was on "Strategic Planning and Problem Solving in the 21st Century" and some of the course materials were filled with quotes, (Zig Ziglar, Lincoln, Dale Carnegie, etc) this being the one quote I never forgot, anonymous no less. If you see my earlier post, you'll see that the actual quote from circa 1923 differs slightly from what you learned at Harvard. It is slightly amusing to me that Harvard missed / failed to give the source, but maybe the person who compiled the quotes there didn't want to be seen quoting ad copy from I.C.S. of Scranton?
|
|
|
Post by mnkdfann on Feb 27, 2022 10:52:09 GMT -5
I'll end my contribution today with one of my favorite quotes that may hold some truth about what I've just written, "Upon the plains of hesitation bleached the bones of countless millions who sat down to WAIT and while waiting they died." - ANONYMOUS If it is your favourite quote, then you may find this interesting. PHILADELPHIA, July 3, 1970—George W. Cecil, a retired vice president and director of the N. W. Ayer & Son, Inc.., the advertising agency, died yesterday in Pennsylvania Hospital. He was 78 years old. Mr. Cecil, who coined the term “coffee break” and other well‐known slogans, was credited with having written more than $100‐million worth of advertising during his 53‐year association with the agency. Mr. Cecil came to Ayer in 1917 and served as head of the copy department from 1936 until 1945. He became a vice president and director in 1936 and retired in 1967. He is perhaps best remembered for a sentence written in an advertising campaign for the International Correspondence Schools of Scranton, Pa., and picked up by Adlai E. Stevenson who used it as a futile call for approval from the electorate in his unsuccessful 1952 campaign for the Presidency: “On the plains of hesitation bleach the bones of countless millions, who, at the dawn of victory, sat down to wait—and waiting, died.” The full obit is at this link: www.nytimes.com/1970/07/04/archives/george-w-cecil-78-exadvertising-aide.html The I.C.S. ad takes the form of a one page story, called The Warning of the Desert by William A. Lawrence. It appears in various issues of Popular Science circa 1923. Easy enough to find with a simple Google search. This link may take you there: books.google.ca/books?id=vdcDAAAAMBAJ&lpg=PA113&dq=warning%20desert%20lawrence%20william%20hesitation&pg=PA113#v=onepage&q=warning%20desert%20lawrence%20william%20hesitation&f=false
|
|
|
Post by mnkdfann on Feb 25, 2022 23:51:53 GMT -5
We discussed it here a month ago. I'm sure it is searchable. I know you discussed it but I don’t believe it’s accurate. www.newstimes.com/business/article/Connecticut-s-second-largest-pharmaceutical-16788660.php DANBURY — On the heels of heralded headquarters moves from New York to Stamford, Connecticut has another transplant — this time in Danbury, though municipal officials are already familiar with the corporation that now calls the city home. MannKind is now designating Danbury as principal executive office in filings with the U.S. Securities and Exchange Commission, with the company having long operated an insulin packaging plant there. Last week, CEO Michael Castagna confirmed the company now regards Danbury as its headquarters during a virtual conference sponsored by investment bank H.C. Wainwright. A spokesperson said Wednesday the company made the decision considering a major expansion under way at its Danbury plant and the facility’s “increasing strategic importance” to the company. The company did not provide immediate comment on whether executives will be moving cross-country to Danbury. Inventor and entrepreneur Alfred Mann founded MannKind in the Los Angeles area, and stepped down as CEO in 2015, a year before his death at age 90. MannKind’s office is in Westlake Village at the base of the Santa Monica Mountains. [Much more at link, with a lot of ads between paragraphs.]
|
|
|
Post by mnkdfann on Feb 25, 2022 16:20:23 GMT -5
Any idea what their jobs were? Maybe they were all in CA which is why the HQ is moving to Danbury. They didn't have an excessive number of employees before the layoff. I hope they weren't afrezza salespeople. Quotes from yesterday's call below. One could suggest that sales agents in non-viable territories may have been let go through 'optimizing'. The other suggests that at least some reps remain. So, who knows. "As you look at 2022, we've optimized our Afrezza footprint to make sure all of our sales are territories are viable and they have positive growth potential." "So the more confidence we have that COVID is not resurging and our reps aren’t going to be locked out of offices, the more confidence we’ll have in terms of continuing to build back up on that sales force, as we get a new team in place, we have all new marketers, all new managers really good focused team here driving us forward on Afrezza."
|
|
|
Post by mnkdfann on Feb 25, 2022 9:57:01 GMT -5
investors.mannkindcorp.com/node/18191/htmlHeld-to-Maturity Investments — Investments consist of highly liquid investments that are intended to facilitate liquidity and capital preservation. As of December 31, 2021, the Company held $79.9 million of short-term investments and $56.6 million of long-term investments. As of December 31, 2020, the Company did not hold any investments.
Held-to-Maturity Investments — The Company’s investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. For the year ended December 31, 2021, the Company held short-term and long-term investments of debt securities, including commercial paper and bonds. The Company assesses whether it has any intention to sell the investment before maturity, whether any declines in fair value are the result of credit losses, as well as whether there were other-than-temporary impairments associated with the available for sale investment. The Company intends to hold its investments until maturity; therefore, these investments are stated at amortized cost. The investments with maturities less than 12 months are included in short-term investments and investments with maturities in excess of twelve months are included in long-term investments in the consolidated balance sheets. I have to hand it to Steve Binder. As of December 31, 2020, the Company did not hold any investments. Perhaps Steve Binder is a chart reader. How do you figure? Not all investments are the same. Seems they invested in a lot in bonds and Treasury securities, for example. It appears that 2021 was, generally speaking, a lousy year to invest in those. From Marketwatch: The total U.S. domestic bond market [in 2021] lost 1.9% last year, as judged by the Vanguard Total Bond Market ETF BND, -0.08%. Long-term Treasurys lost even more, losing 5.0% (as judged by the Vanguard Long-Term Treasury ETF VGLT, -0.34% ).
With rising interest rates forecast, 2022 looks to be even worse.
|
|
|
Post by mnkdfann on Feb 24, 2022 13:44:37 GMT -5
Woke up to see the MNKD pps drop and thought ... The Russian invasion did this Now that I am really up ... my thoughts are ... "Hey Martha ... it's another buying opportunity !!!" Current pps is still above my average cost per share ... but, I'll have to wait till the 1st for my next influx of $$$. But, that's mytakeonit So maybe you can lower your cost basis then?
|
|
|
Post by mnkdfann on Feb 24, 2022 12:35:47 GMT -5
I’m hearing Nate sent out emails to people anybody get one? Saying what? Or what have you heard?
|
|
|
Post by mnkdfann on Feb 23, 2022 21:41:00 GMT -5
I do not listen to his type of music. I'm mostly ignorant of Kanye West's music (he's done a lot), but he does have some songs I like. Including those he did with Paul McCartney, and with Estelle (American Boy), and Keri Hilson (a version of Pretty Girl Rock). He's collaborated with a ton of other people, including Elton John. I like some of his solo songs as well, but I can't name those off-hand. West is so prolific that I wouldn't be surprised if you actually do like some songs he wrote the music / lyrics for, or did backing vocals in, without you knowing it. But, yeah, he does seem to have suffered from some personal issues in recent years.
|
|
|
Post by mnkdfann on Feb 23, 2022 14:34:31 GMT -5
|
|
|
Post by mnkdfann on Feb 21, 2022 23:21:55 GMT -5
Not to be Debbie downer. But a lot of you sound super hypocritical, we support a company that sells their insulin for 1.5k an RX. New drugs cost money. US is the king of new drug development. Lose this and then you got your affordable healthcare. Maybe. At least, that's what the U.S. drug lobby would have you believe. Others differ from that opinion. I'm sure the article below isn't the final word, but it raises questions. www.ncbi.nlm.nih.gov/pmc/articles/PMC2866602/We explored whether the United States, which does not regulate pharmaceutical prices, is responsible for the development of a disproportionate share of the new molecular entities (NMEs; a drug that does not contain an active moiety previously approved by the Food and Drug Administration) produced worldwide.
Methods. We collected data on NMEs approved between 1992 and 2004 and assigned each NME to an inventor country. We examined the relation between the proportion of total NMEs developed in each country and the proportion of total prescription drug spending and gross domestic product (GDP) of each country represented.
Results. The United States accounted for 42% of prescription drug spending and 40% of the total GDP among innovator countries and was responsible for the development of 43.7% of the NMEs. The United Kingdom, Switzerland, and a few other countries innovated proportionally more than their contribution to GDP or prescription drug spending, whereas Japan, South Korea, and a few other countries innovated less.
Conclusions. Higher prescription drug spending in the United States does not disproportionately privilege domestic innovation, and many countries with drug price regulation were significant contributors to pharmaceutical innovation.
|
|